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Abstract
Methionyl-tRNA synthetase (MetRS) specifically binds its methionine substrate in an induced fit
mechanism, with methionine binding causing large rearrangements. Mutated MetRS able to
efficiently aminoacylate the methionine (Met) analog azidonorleucine (Anl) have been identified by
saturation mutagenesis combined with in vivo screening procedures. Here, to reveal the structural
basis for the altered specificity, the crystal structure of such a mutated MetRS was determined in the
apo form as well as complexed with Met or Anl (1.4 to 1.7 Å resolution). The mutations result in
both the loss of important contacts with Met, and in the creation of new contacts with Anl, thereby
explaining the specificity shift. Surprisingly, the conformation induced by Met binding in wild-type
MetRS already occurs in the apo form of the mutant enzyme. Therefore, the mutations cause the
enzyme to switch from an induced fit mechanism to a lock and key one, thereby enhancing its catalytic
efficiency.
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INTRODUCTION
Enzymes are highly efficient and specific catalysts that use the substrate binding energy to
stabilize the transition state of the reaction 1; 2; 3; 4. There are two main molecular mechanisms
that underlie the utilization of substrate binding energy. In the lock and key mechanism, the
binding pockets for the substrates exist in full form in the free enzyme. The substrates readily
bind and the reaction is driven because the active site has better complementarity to the
transition state of the reaction than to the substrates at the ground state. In the induced fit
mechanism, complementarity to the transition state is not achieved before substrate binding.
Instead, a part of the binding energy is used to distort the enzyme in such a way that
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complementarity is obtained only after binding. Therefore, although induced fit can provide
some advantages in the functioning of an enzyme, this mechanism is intrinsically less efficient
since a smaller amount of the substrate binding energy remains available for reaching the
transition state 3.
Each aminoacyl-tRNA synthetase (aaRS) catalyzes the attachment of an amino acid to its
cognate tRNAs. These enzymes have been thoroughly studied for many years because of their
pivotal role in faithful decoding of the genetic message (reviewed in 5; 6; 7; 8). Catalysis by
aaRS is a two-step process. The amino acid is first activated into aminoacyl-adenylate in an
ATP-dependent manner, and then transferred onto the 3′ end of tRNA. The problem of the
discrimination by aaRS of amino acids depends on the considered system. In some cases, the
correct substrate is sufficiently different from incorrect ones to be specifically recognized at
the level of enzyme binding 9. However, some amino acids such as valine and isoleucine differ
only by a methylene group. In these cases, the corresponding aaRS have evolved proofreading
mechanisms in order to achieve a sufficient level of discrimination in vivo. Although
methionyl-tRNA synthetase (MetRS) displays a high level of specificity for the binding and
activation of methionine, it also can activate homocysteine at a significant rate. To avoid
erroneous homocysteylation of tRNAMet, MetRS-bound homocysteinyl adenylate is rapidly
converted into homocysteine thiolactone by the enzyme 10; 11. E. coli MetRS is a homodimer
from which a fully active monomer can be generated upon truncation of nearly 120 C-terminal
residues 12; 13; 14. Several X-ray structures of this active monomer, corresponding to the free
enzyme as well as to complexes with methionine or methionyl-adenylate analogs, are known
15; 16; 17. These studies have concluded that methionine binds the enzyme in an induced fit
mechanism, with a large rearrangement of aromatic residues enabling the protein to form a
hydrophobic pocket around the ligand side-chain. Among the key residues involved in Met
binding, the main chain NH of L13 as well as with the side chains of Y260 and H301 facilitate
the recognition of the sulphur atom of Met 16; 17; 18.
Saturation mutagenesis targeting such important residues coupled with high-throughput
screening procedures have led to the isolation of several MetRS mutants able to efficiently
charge methionine analogs onto tRNAsMetin vivo 19; 20; 21; 22. We recently reported the
optimization of these screening procedures, and their use to isolate MetRS variants with both
improved activity towards the Met-analog azidonorleucine (Anl) and higher selectivity against
Met 22. The aim of the present work is to decipher the structural basis for remodelling the amino
acid specificity of such variants. The high-resolution X-ray structures of a representative
variant, MetRS-SLL, carrying Ser at position 13 and Leu at positions 260 and 301, as well as
of its complexes with Met or Anl are described. Modification of the amino acid cavity results
in both the loss of important contacts with Met, and in the creation of new contacts with Anl,
thereby shifting the specificity of the enzyme. Interestingly, we observe that the conformation
induced by Met binding in wild-type MetRS occurs in the free form of the mutant enzyme.
Therefore, the mutations cause the enzyme to switch from an induced fit to a lock and key
mechanism, increasing its catalytic efficiency. This effect is important to render the mutant
enzyme usable for in vivo incorporation of non-canonical amino acids into proteins.
RESULTS AND DISCUSSION
Crystallization of MetRS-SLL
Crystallization of the active truncated monomeric forms of E. coli MetRS (M547 or M551;
13) using ammonium citrate as precipitant yields two closely related types of crystals. Most of
the crystals form thin plates, belonging to the P21 space group with cell parameters a=78.2 Å,
b=46.3 Å, c=87.7 Å, β=109.1°. Beside this major species called type 1, a few percent of rod-
shaped crystals can be observed. These type 2 crystals belong to the same P21 space group but
are characterized by a slightly smaller c parameter (c=86.3 Å) and a slightly smaller β angle
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(β=107.9°). Crystallization of M547 or M551 in the presence of methionine yields type 2
crystals, even when crystallization is triggered by microseeding with type 1 crystals (16 and
our unpublished observations). MetRS-SLL was crystallized at 6°C in the same conditions as
the wild-type M551 enzyme (3 mg/mL protein in 1.08 M ammonium citrate, 30 mM potassium
phosphate, pH 7.0) by microseeding with type 1 crystals of the M551 enzyme. Notably, MetRS-
SLL crystals, visible after a few days, were all rod-shaped. Their cell parameters (a=78.2 Å,
b=45.3 Å, c=86.0 Å, β=107.3°; Table 1) corresponded to those of type 2 crystals.
Overall structure of the MetRS-SLL enzyme
The structure was solved by rigid body refinement of the M551 enzyme model (PDB 1QQT;
15. After several round of energy minimization and manual rebuilding, the model was refined
to 1.7 Å resolution. The structure is similar to that of the wild-type truncated monomer and is
composed of four parts. (i) The Rossmann fold domain contains the active site. (ii) The
connective polypeptide 1 (CP1) contains a zinc-binding knuckle and is inserted between the
two halves of the catalytic domain 23; 24. (iii) The KMSKS domain borders the catalytic
crevice, and contains residues critical for catalysis 25; 26. (iv) The C-terminal helix bundle
domain is responsible for recognition of the CAU anticodon of tRNAsMet 27; 28; 29; 30.
As compared to the wild-type M551 enzyme, both the zinc-binding module and the anticodon-
binding region display a slight rotation toward the active site crevice (Fig. 1). Such changes
were already observed in the structure of the M551:Met complex. Accordingly, the MetRS-
SLL structure can be superimposed to that of the M551:Met complex (PDB id 1F4L; 16 with
an rmsd of 0.22 Å for all Cα atoms, while the rmsd is 0.76 Å upon superimposition of MetRS-
SLL to M551.
Closer examination of the active site of MetRS-SLL shows important rearrangements of
aromatic residues. More precisely, the side chains of W229, W253, F300 and F304 largely
rotate, in such a way that W229 stacks on F304 and W253 stacks on F300. Such interactions
do not occur in the free wild-type enzyme, where stacking contacts imply Y251 with W253 on
the one hand, and F300 with F304 on the other hand (Fig. 2). A notable consequence of the
motions of W253 and F300 is to dramatically reduce the size of the active site cavity.
Remarkably, these rearrangements exactly match those occurring in the wild-type enzyme
upon methionine binding, where the enzyme switches from a “met-off” to a “met-on”
conformation 16; Fig. 2). The only exception is the side chain of Y15, which is in a conformation
leaving the methionine binding cavity open in the MetRS-SLL and M551 structures, while
Y15 is in a conformation that locks methionine in the cavity in the M551:Met structure 17; Fig.
2). As noted above, both MetRS-SLL and M551:Met crystallize to form type 2 crystals. This
raises the question of the relationships between the type of the crystals and the crystalline
conformation of MetRS. In order to analyze this issue, the structure of the wild-type M547
enzyme within type 2 crystals was determined. On the whole, the same overall shape as that
obtained in other type 2 crystals is observed, with the zinc-binding module and the anticodon-
binding region slightly rotated toward the active site. However, the conformations of side
chains around the methionine-binding crevice clearly match those in the unmutated enzyme in
the type 1 crystals, but not those in MetRS-SLL. Therefore, it can be concluded that the
observed reorganization of aromatic side chains in MetRS-SLL is a consequence of one or
several of the L13S, Y260L and H301L mutations.
Binding of methionine and of azidonorleucine to MetRS-SLL
MetRS-SLL is known to activate both Anl and 6,6,6-trifluoronorleucine (Tfn) 21; 22. In order
to study the binding of these methionine analogues to the MetRS-SLL enzyme, crystallization
experiments of the mutant enzyme were carried out in the presence of either 35 mM Anl, 10
mM Tfn or 35 mM methionine. The corresponding structures clearly showed the presence of
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Anl or of Met in the expected cavity. No density corresponding to Tfn was however visible.
Higher concentrations of the unnatural amino acid could not be used because of its limited
solubility in the crystallization medium. Binding of Tfn was therefore not further studied.
The methionine substrate binds MetRS-SLL exactly at the same site as in unmutated MetRS.
However, the three mutations lead to an increase of the size of the cavity on the side of the
methyl group, and to the loss of favorable electrostatic contacts of the sulfur atom of bound
Met with the OH of Y260 and NεH of H301. Contrasting with the situation in wild-type MetRS,
the methionine binding pocket is preformed in MetRS-SLL, in such a way that very few
motions occur upon complex formation. The most obvious one concerns Y15, which rotates
to lock Met in its cavity like it does in the wild-type MetRS:Met structure. This motion occurs
together with those of neighboring residues, in such a way that the C11-N17 peptide is slightly
displaced upon methionine binding (Figure 3). Finally, the side chain of Y91 rotates by 30° to
make a hydrogen bond with the sulfur atom of C11. Concomitantly, the main chain of I48 is
slightly displaced, with its alpha and carbonyl carbons making van der Waals contacts with
Y91.
Binding of the non-natural amino acid Anl occurs at the same site as that of Met. For both Met
and Anl, the amino group is held by the carboxylate of D52 and by the main chain carbonyl of
S13. The carboxylate group of the ligand interacts with 5 water molecules. Enlargement of the
cavity caused by the Y260L and H301L mutations allows to accommodate the longer side
chain of Anl. Indeed, a Y at position 260 as well as a H at position 301 would cause severe
steric clashes with the azido moiety of Anl, thereby precluding its binding. The N3 atom of the
azido group of Anl occupies the exact position of a water molecule (Wat5 in Fig. 3C) in the
MetRS-SLL unliganded structure. Notably, Wat5 occupies the same position as the OH group
of Y260 in the wild-type MetRS. The N3 of Anl interacts with a water molecule (Wat1 in Figs.
3 and 4), also present in the structure of the wild-type enzyme. Wat1 is held by the hydroxyl
of T10 and by the carbonyl of F292. Despite the removal of several water molecules from the
binding pocket upon Anl binding, Wat2 remains in the vicinity of Anl in the complex (Figs.
3B and 4). Wat2 is tightly held by (i) the hydroxyl and amino groups of S13, (ii) the carbonyl
of C11 and (iii) a water molecule. Notably, Wat2 is still present when the active site is occupied
by Met (Fig. 3C). This water molecule is likely to enhance the Anl binding affinity by making
a favorable electrostatic contact with the N2 nitrogen in the azido group of the ligand (distance
2.95 Å). Furthermore, the presence of Wat2 in the MetRS-SLL:Anl complex may also
indirectly contribute to Anl binding by diminishing the number of water molecules to be
removed from the active site for the amino acid ligand to bind. In this context, the case of S13
deserves particular attention. In the unliganded structure, the side chain of this residue can
adopt two equally populated conformations. In one conformation (conformation 1), the
hydroxyl group interacts with a water molecule (Wat4) held by the carbonyl of A256. In the
second conformation (conformation 2), the hydroxyl of S13 interacts with the carbonyl of A50
and with Wat2. Upon Anl or Met binding, S13 becomes predominantly restrained to
conformation 2, where it tightens the binding of the Wat2 molecule.
Role of L13S, Y260L and H301L mutations in modifying the substrate specificity of MetRS
The most remarkable feature of MetRS-SLL is its “ready to bind” conformation. This facilitates
the binding of new ligands at the amino acid site, by lowering the part of the binding energy
spent for changing the conformation of the enzyme 3. How do the three mutations cause MetRS-
SLL to be in the met-on conformation, even in the absence of a bound amino acid? A first
reason is that a Leu at position 301 is not compatible with the met-off conformation of F300,
which puts the CD2 of F300 at only 2.8 Å away from the CD2 of L301. This might favor its
displacement and its subsequent stacking on W253. Second, the H301L and Y260L mutations
create a hydrophobic environment favoring the position of W253 corresponding to the met-on
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conformation. Such stacking of F300 on W253 is likely to trigger the whole met-on
conformation. Indeed, previous structural studies of the binding of Met analogs to MetRS led
to the idea that motion of W253 is a primary event in the conformational transition 17. Its
stacking on F300 would release F304 and open the new position for W229 stacked on F304.
In vivo screening for MetRS variants able to incorporate Anl or Tfn strongly selected Leu at
position 301 21; 22. Moreover, the most efficient mutants, both in vivo and in vitro, also carry
Leu at position 260. More precisely, in the high stringency screen for mutants charging Anl,
more than 80 % of the selected MetRS carry the H301L mutation, the other ones having either
H301I or H301V 22. At position 260, all mutants but one harbor a hydrophobic residue, with
more than 50% having Leu. According to the above analysis of the structure, it is likely that
most, if not all, of the mutants selected for their catalytic efficiency also display the met-on
conformation. This observation favors the idea that the met-on conformation, as observed in
MetRS-SLL, is important to achieve a high catalytic efficiency with non-methionine substrates.
Notably, L260 and L301 side chains make van der Waals contacts (3.9 to 4 Å) with the three
azido nitrogens of Anl. This observation might explain the selection of Y260L and H301L,
beyond the importance of the occurrence of hydrophobic residues at this position for the met-
on conformation, as discussed above. Concerning mutations at position 13, either small polar
residues (Ser, Asn or Cys) or proline lead to the highest efficiencies for Anl activation and to
reduced efficiencies for Met activation 22. Actually, the nature of the amino acid at position
13 has a greater effect on the activation of Met than on the activation of Anl 22. The deleterious
effect of the proline mutation toward Met binding can easily be explained by the involvement
of the main chain NH of L13 in a hydrogen bond with the sulfur of the Met ligand in wild-type
MetRS 16; 17. In the structure of the MetRS-SLL mutant, both the side chain and the main chain
NH of S13 interact with Wat2. By stabilizing this water molecule, the side chain of S13 is
likely to render the NH main chain less available for interacting with the S group of the
methionine substrate. This may explain why the L13S mutation disfavors Met binding.
Similarly, the different behaviors regarding Met binding of mutants with Asn or Cys at position
13 may also be correlated with the ability of the corresponding side chains to favor masking
of the main chain NH of residue 13 21; 22. Finally, the side chain of residue at position 13 also
influences the catalytic efficiency of Anl activation 22. A favorable electrostatic contact of the
Wat2 molecule with the azido group of Anl (Figs. 3B and 4) may at least partly explain the
favorable effect toward Anl binding of small polar side chains at this position. In addition,
several water molecules must be displaced to allow Anl binding (Fig. 3). The possibility for
the enzyme to tightly bind a water molecule such as Wat2 in the vicinity of the substrate may
lower the cost for such desolvation of the amino acid binding cavity. In the case of Pro,
favorable van der Waals contacts with the Anl side chain may substitute for the favorable effect
of Wat2.
Concluding remarks
This work describes the origins of amino acid substrate recognition by a methionyl-tRNA
synthetase mutant with modified specificity. In MetRS-SLL, modification of the binding cavity
results in both the loss of important contacts with Met, and the creation of new contacts with
Anl, thereby shifting the specificity of the enzyme. With wild-type MetRS, it has been
demonstrated that conformational changes induced by the Met ligand are involved in binding
the cognate amino acid 16. Since this “met-on” conformation is maintained in the
MetRS:methionyl-adenylate complex 17, this conformation is likely to exist during the
transition state of the activation reaction also, and consequently play an important role in
driving the enzyme toward catalysis. In this context, a striking consequence of the mutations
in MetRS-SLL is that the free enzyme adopts the “met-on” conformation. Consequently, less
substrate binding energy is spent to distort the enzyme for reaching the transition state of the
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reaction. Therefore, MetRS-SLL is likely to owe its enlarged substrate specificity to the
possibility to more easily reach the transition state, which increases its catalytic efficiency.
This illustrates that changing the mode of substrate binding can be used to engineer an enzyme.
Finally, the new amino acid substrate of MetRS-SLL studied here, Anl, contains a polar group
at the end of its side chain. It should be pointed out that this polar group is bound by a water
molecule. This indicates that solvent molecules must carefully be considered in the course of
designing engineered active sites for new ligands.
EXPERIMENTAL PROCEDURES
Expression and purification of the MetRS variants
The unmutated monomeric version of E. coli MetRS truncated at residue 548 (M547) was
produced from the pBSM547 plasmid and purified as described 18; 29.
The pMTY21-sll plasmid codes for an N-terminally 6XHis-tagged M547 MetRS regulated by
an IPTG inductible T5 promoter 21. This plasmid carries a modified MetRS gene leading to
expression of the MetRS-SLL mutant (L13S, Y260L, H301L). E. coli JM101Tr cells 31
transformed with pMTY21-sll were grown at 37°C in 1 L of 2xTY medium containing
ampicillin (50 μg/mL) and induced with 1 mM IPTG at an OD650 of 0.6. The culture was then
continued for 12 h at 37°C.
Purification of MetRS-SLL—A 1-litre culture of cells overproducing MetRS-SLL were
harvested, resuspended in 50 mL of buffer A (50 mM NaCl, 10 mM HEPES pH 7.5, 3 mM 2-
mercaptoethanol) and disrupted by sonication. After centrifugation, the supernatant was loaded
onto a column (5 mL) containing Talon affinity resin (Clontech). The resin was washed with
50 mL of buffer A and then with 50 mL buffer A supplemented with 10 mM imidazole. The
protein was eluted with buffer A containing 125 mM imidazole. The pooled sample was then
dialyzed against buffer A. Finally, the protein was loaded onto a column (20 mL) containing
Q-Hiload resin (Amersham) equilibrated in buffer A and eluted with a 300 mL gradient from
50 to 450 mM NaCl in 10 mM HEPES pH 7.5, 3 mM 2-mercaptoethanol. Fractions containing
the protein were pooled, dialyzed against buffer A and concentrated to 6 mg/mL by using a
Centricon-30 concentrator (Amicon). Protein concentration was deduced from A280
measurement using an extinction coefficient of 1.72 cm2/mg 32. Approximately 50 mg of
protein per litre of culture was obtained.
Crystallization of MetRS-SLL
Crystals of M547 or of MetRS-SLL were obtained in a solution containing 30 mM KPO4, 4
mM 2-mercaptoethanol,1.08 mM ammonium citrate and 3.6 mg/mL of protein by
microseeding with crystals of M551 at pH 7.0 15. For ligand binding studies, the amino acid
was added to the crystallization medium prior to microseeding (Table 1). Final concentrations
during crystallization were 35 mM for methionine, 35 mM for Anl or 10 mM for Tfn. For data
collection, crystals were first stabilized in 1.4 M ammonium citrate plus 30 mM potassium
phosphate (pH 7.0), quickly soaked in the same solution plus 25 % v/v of glycerol and then
flash-cooled in liquid ethane. Data were collected using synchrotron sources at either ESRF
(Grenoble, France) or SOLEIL (Gif sur Yvette, France). Diffraction images were analyzed
with the XDS program 33 and the data further processed using programs from the CCP4
package 34. Data statistics are summarized in Table 1.
Structure solution and refinement
Each structure was solved by rigid body refinement of the M551 model (PDB id 1QQT), using
the CNS program 35. After calculation of initial density maps, the model was manually adjusted
using O 36. Each model was refined by cycles of manual adjustment and addition of water
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molecules followed by conjugate gradient minimization using either CNS 35 or PHENIX 37.
Refinement statistics are summarized in Table 1.
Accession numbers
Coordinates and structure factors have been deposited at the Protein Data Bank with IDs 3H97,
3H99, 3H9B and 3H9C.
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Overall shape of the mutant enzyme. The three views compare the C alpha backbone of MetRS-
SLL (grey) to those of unliganded MetRS from type 1 crystals (PDB id 1QQT; black, left
view), of the MetRS:met complex (PDB id 1F4L; black, central view) and of unliganded
MetRS from type 2 crystals (black, right view). Figures 1, 2 and 3 were drawn using PyMOL
(www.pymol.org). In the left view, only residues 4–121 and 189–345 were used for the
superimposition of the two structures. In the center and right views, all C alpha atoms were
superimposed.
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Unliganded MetRS-SLL is in the “met-on” conformation. Top panel: the active site region of
unliganded MetRS-SLL (yellow) was superimposed to that of unliganded MetRS (PDB 1QQT;
blue). Motions of aromatic residues are indicated by arrows. Bottom panel: same as top panel
but unliganded MetRS was replaced by MetRS:Met (PDB 1F4L; blue). The bound methionine
is shown in green.
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Binding of azidonorleucine and methionine to MetRS-SLL. The three panels show stick
representations of the amino acid binding sites of free or liganded MetRS-SLL, all in the same
orientation. Carbon atoms are in yellow, nitrogen atoms in blue and oxygen atoms in red. Water
molecules are drawn as red spheres. Relevant hydrogen bonds are indicated by grey dotted
lines. Panel A: unliganded MetRS-SLL; the two conformations of the side chain of S13 are
drawn, with conformation 1 in standard colours and conformation 2 with the hydroxyl oxygen
in green. Panel B: MetRS-SLL:Anl complex. Only the major conformation of S13 is
represented. The electrostatic interaction between Wat2 and the N2 atom of Anl is symbolized
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by a blue dotted line. Panel C: MetRS-SLL:Met complex. Only the major conformation of S13
is represented.
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Schematic representation of hydrophobic (red dotted lines) and electrostatic (green dotted
lines) interactions made between MetRS-SLL and azidonorleucine. Anl is represented with
blue bonds. Carbons are in black, nitrogens in dark blue, oxygens in red and sulfurs in yellow.
Water molecules are symbolized as light blue spheres. Relevant hydrogen bonding distances
are indicated in Å. The electrostatic interaction between Wat2 and the N2 atom of Anl is
indicated by a blue dotted line. The figure was drawn with Ligplot 38.
Schmitt et al. Page 14

























Schmitt et al. Page 15
Table 1
Crystallographic and refinement data.
Crystal MetRS-SLL MetRS-SLL:Met MetRS-SLL:Anl M547
X-ray source ESRF-id14eh2 ESRF-id14eh2 ESRF-id14eh2 SOLEIL-Proxima1
Data collection wavelength (Å) 0.933 0.933 0.933 0.980
Space Group P21 P21 P21 P21








Unique reflections 59 541 111 291 86282 109028
Resolution (Å) 1.7 1.4 1.5 1.4
Completeness (%)/Redundancy 93.4/2.5 98.0/2.8 93.1/3.1 94.7/3.1
Rsym (I) (%)1 2.3 (4.2) 2.5 (7.5) 2.6 (9.4) 5.7 (30.0)
R/Free-R2 (%) 15.9/18.2 16.8/18.0 16.5/18.8 16.5/19.1
rmsd bonds (Å)/angles (°) 0.0046/1.2 0.0043/1.2 0.0044/1.2 0.006/1.1





1 Zn, 1 Met
4–547, 1161
waters, 2 citrates,
1 Zn, 1 Anl
4–547, 1095
waters, 1 citrate, 1
Zn
Mean Bvalues enzyme residues/
Zn/solvent/ligand
8.0/6.0/23.9/- 8.0/5.8/20.7/9.7 8.6/6.0/24.8/11.2 12.5/26.5/9.8/-
1
Values in parentheses are Rsym (I) in the highest shell of resolution.
2
Rfree was calculated with 6% of the reflections.
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